A prospective observational trial examining the value of serum procalcitonin in the diagnosis of pleural infection

C. E. Hooper, A. J. Morley, J. Jukes, J. E. Harvey, N. A. Maskell (Bristol, United Kingdom)

Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases
Session: Novel biomarkers and old parameters in approaching pulmonary diseases
Session type: Oral Presentation
Number: 2104
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. E. Hooper, A. J. Morley, J. Jukes, J. E. Harvey, N. A. Maskell (Bristol, United Kingdom). A prospective observational trial examining the value of serum procalcitonin in the diagnosis of pleural infection. Eur Respir J 2010; 36: Suppl. 54, 2104

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Value of neutrophil-to-lymphocyte ratio, procalcitonin, and C-reactive protein in help to predict weaning outcome: a prospective, observational cohort study
Source: International Congress 2017 – COPD and weaning
Year: 2017

COVID-19 pneumonia and clinical follow-up: results of a prospective cohort
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021


Serum ferritin as a prognostic marker of pneumonia: a prospective, single center study
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018


Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021


A prospective study using serum mesothelin to monitor mesothelioma.
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017




D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019

The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study
Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018
Year: 2019



Procalcitonin as a predictor of pneumonia in patients hospitalized with acute exacerbation of COPD: a prospective observational study
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Prospective multicenter observational study comparing ambulatory management of spontaneous pneumothorax versus hospital care: PNEUMOPECO study.
Source: International Congress 2019 – Treatment of airway diseases in primary care
Year: 2019

Prognostic value of plasma D-dimer level in adults with community-acquired pneumonia – A prospective study
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Diagnosing COVID-19 pneumonia in a pandemic setting: Lung Ultrasound versus CT (LUVCT) – a multicentre, prospective, observational study
Source: ERJ Open Res, 6 (4) 00539-2020; 10.1183/23120541.00539-2020
Year: 2020



Lung ultrasound aeration score for prognostication in invasively ventilated COVID-19 patients: multicenter observational study.
Source: Virtual Congress 2021 – Thoracic ultrasound: future applications and current evidence
Year: 2021



The value of additional testing in physician diagnosed asthma: A prospective pilot study
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012


Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021



Effectiveness of treatments for severe sepsis: a prospective multicentre observational study in Spanish ICUs
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009


COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol
Source: Eur Respir J, 58 (3) 2100929; 10.1183/13993003.00929-2021
Year: 2021



Prospective six months follow-up analysis of the serological response to SARS-CoV-2 in a cohort of patients admitted for COVID-19 pneumonia
Source: Virtual Congress 2021 – Chronic COVID - 19
Year: 2021



Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study
Source: Eur Respir J, 51 (4) 1702037; 10.1183/13993003.02037-2017
Year: 2018